Rosaceahttps://en.wikipedia.org/wiki/Rosacea
Rosacea bụ nsogbu akpụkpọ ahụ na-adịte aka nke na-emetụta ihu. Ọ na-ebute ọbara, ọzịza, na obere arịa ọbara gbasasịrị elu. Ọtụtụ mgbe, imi, ntì, ọkpọiso, na agba na-akacha emetụta. Imi na-acha uhie uhie, na mgbasa, nwere ike ibute ọrịa siri ike, nke a na-akpọ “rhinophyma”. Ndị na-emetụta ya bụkarị ndị dị afọ 30 ruo 50, karịsịa ụmụ nwanyị. Ndị Caucasian na-emetụta ya karịa. Dermatitis kọntaktị na-adịghị ala ala nke ihe ịchọ mma na-akpata, mgbe ụfọdụ, a na-eziga ya dịka rosacea.

Ihe ndị nwere ike ime ka ọnọdụ ahụ ka njọ gụnyere okpomọkụ, mgbatị ahụ, ìhè anyanwụ, oyi, nri na-esi ísì ụtọ, mmanya, nkwụsịtụ, nchekasị uche, ma ọ bụ iji ude steroid n’ahụ. Ọgwụgwọ na-abụkarị metronidazole, doxycycline, minocycline, ma ọ bụ tetracycline.

○ Nchọpụta na Ọgwụgwọ
Gbaa mbọ hụ na ọ bụghị dermatitis kọntaktị nke ihe ịchọ mma kpatara. A na-achọkarị ọgwụgwọ ogologo oge. Minocycline dị irè maka rosacea na-egbuke egbuke. Brimonidine nwere ike ibelata ntupu site na igbochi arịa ọbara.

#Minocycline
#Tetracycline
#Brimonidine [Mirvaso]

○ Ọgwụ OTC
Mgbaàmà dermatitis kọntaktị mgbe ụfọdụ yiri nke rosacea. Ejila ihe ịchọ mma na-adịghị mkpa n’ahụ ruo ọtụtụ izu, ma rie ọgwụ antihistamine oral.
#OTC antihistamine
☆ AI Dermatology — Free Service
Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
  • Rosacea — na-emetụkarị ntì na imi.
  • Rosacea na-ebute site na steroid — oke iji ọgwụ steroid nwere ike ibute ọnọdụ a.
  • Imi bụ ebe a na-ahụkarị nsogbu ahụ na-eme.
References Rosacea Treatment: Review and Update 33170491 
NIH
Anyị ga-atụle ọgwụgwọ kachasị ọhụrụ maka rosacea. Anyị ga-ekpuchi nlekọta anụ ahụ, ihe ịchọ mma, ude, ọgwụ, lasers, injections, yana ọgwụgwọ ahaziri maka ụdị rosacea dị iche iche, ijikwa nsogbu ahụike metụtara ya, na ijikọta ọgwụgwọ. Ihe a niile bụ n'ihi ụzọ ọhụrụ a ga-esi chọpụta nkewa rosacea dabere na ọdịdị ya.
We summarize recent advances in rosacea treatment, including skin care and cosmetic treatments, topical therapies, oral therapies, laser-/light-based therapies, injection therapies, treatments for specific types of rosacea and treatments for systemic comorbidities, and combination therapies, in the era of phenotype-based diagnosis and classification for rosacea.
 Rosacea: New Concepts in Classification and Treatment 33759078 
NIH
Rosacea bụ ọrịa akpụkpọ ahụ na-adịte aka nke na-emetụta ntị, imi, agba, na ọkpọ isi. A maara ya maka ịkpata nfụkasị, ọbara ọbara na-apụta ma na-apụ, ọbara ọbara na-adịgide adịgide, ịba ụba nke akpụkpọ ahụ, obere ọnyà na-acha uhie uhie, ọtụ jupụtara n'ọnụ, na arịa ọbara a na-ahụ anya.
Rosacea is a chronic inflammatory dermatosis mainly affecting the cheeks, nose, chin, and forehead. Rosacea is characterized by recurrent episodes of flushing or transient erythema, persistent erythema, phymatous changes, papules, pustules, and telangiectasia.